TransMedics director gifts 18,000 shares of stock

TransMedics Group, Inc. director James R. Tobin reported a bona fide gift transfer of 18,000 shares of common stock on 2026-08-17 from an indirect holding titled "The Tobin 2024 Family Trust," leaving that trust with 0 shares.

Rhea-AI Filing Summary

TransMedics Group, Inc. director James R. Tobin reported a bona fide gift transfer of 18,000 shares of common stock on 2026-08-17 from an indirect holding titled "The Tobin 2024 Family Trust," leaving that trust with 0 shares. Following this reporting, Tobin holds 6,981 shares of TransMedics common stock directly and 155,146 shares indirectly through the "James R. Tobin 2012 Trust."

Insider Trade Summary

18,000 shares gifted

Gift 3 txns

Insider TOBIN JAMES R

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	18,000	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Indirect, By The Tobin 2024 Family Trust); Common Stock — 6,981 shares (Direct); Common Stock — 155,146 shares (Indirect, By the James R. Tobin 2012 Trust)

Key Figures

Shares transferred by gift: 18,000 shares Shares remaining in The Tobin 2024 Family Trust: 0 shares Direct holdings after transaction: 6,981 shares +2 more

5 metrics

Shares transferred by gift 18,000 shares Bona fide gift of common stock from The Tobin 2024 Family Trust on 2026-08-17

Shares remaining in The Tobin 2024 Family Trust 0 shares Total shares following the 18,000-share gift transaction

Direct holdings after transaction 6,981 shares Common stock directly held by James R. Tobin following the reported transactions

Indirect holdings via 2012 Trust 155,146 shares Common stock held indirectly by the James R. Tobin 2012 Trust following the reported transactions

Reported gift price per share $0.0000 per share Price field for the 18,000-share bona fide gift transaction

Key Terms

bona fide gift, indirect ownership, Form 4

3 terms

bona fide gift financial

"The transaction is reported with the code G as a bona fide gift"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

indirect ownership financial

"The shares were held in indirect ownership by The Tobin 2024 Family Trust"

Form 4 regulatory

"The insider reported these changes in a Form 4 ownership filing"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TransMedics Group (TMDX) director James R. Tobin report on this Form 4?

James R. Tobin reported a bona fide gift of 18,000 shares of TransMedics common stock from an indirect trust holding. The filing also updates his remaining direct and indirect shareholdings after this gift transfer.

How many TransMedics (TMDX) shares were transferred by gift in this filing?

The filing reports a gift transfer of 18,000 shares of TransMedics common stock. These shares were held indirectly through "The Tobin 2024 Family Trust" and, after the transfer, that trust shows 0 shares remaining.

What are James R. Tobin’s direct holdings in TransMedics (TMDX) after the reported transactions?

After the reported transactions, James R. Tobin directly holds 6,981 shares of TransMedics common stock. This direct position is separate from his indirect holdings through family trusts disclosed in the same Form 4.

What indirect TransMedics (TMDX) holdings does James R. Tobin report after this Form 4?

Following the gift, Tobin reports 155,146 shares of TransMedics common stock held indirectly by the "James R. Tobin 2012 Trust." The previously reported "Tobin 2024 Family Trust" shows 0 shares remaining after the 18,000-share gift.

Was the 18,000-share TransMedics (TMDX) transaction a sale or a gift?

The 18,000-share transaction is reported as a bona fide gift (transaction code G), not a market sale or purchase. The per-share price field is 0.0000, consistent with a non-cash gift transfer of shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:45 PM Accepted by SEC EDGAR 08/17/2026 - 04:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TOBIN JAMES R

(Last) (First) (Middle)

C/O TRANSMEDICS GROUP, INC.

200 MINUTEMAN ROAD

(Street)

ANDOVER MASSACHUSETTS 01810

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TransMedics Group, Inc. [ TMDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/17/2026		G		18,000	D	$0	0	I	By The Tobin 2024 Family Trust
Common Stock								6,981	D
Common Stock								155,146	I	By the James R. Tobin 2012 Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: /s/ Gerardo Hernandez, Attorney-in-Fact	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)